Seattle Genetics | Ventes

Sales Changement Date
AbbVie USD 14.3B 374M 2023-12
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 7.1M 296K 2023-12
Amgen USD 8.2B 1.29B 2023-12
Astellas Pharma JPY 421.93B 29.78B 2023-12
Bayer EUR 11.86B 1.52B 2023-12
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Celldex Therapeutics USD 259K 1.26M 2023-12
Daiichi Sankyo JPY 446.92B 71.42B 2023-12
Eisai JPY 177.7B 1.09B 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Exelixis USD 479.65M 7.73M 2023-12
Genmab DKK 4.68B 66M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 8.05B 95M 2023-12
Glaxosmithkline GBP 8.05B 95M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Insmed USD 83.69M 4.62M 2023-12
MacroGenics USD 10.72M 323K 2023-12
Merck USD 14.63B 1.33B 2023-12
Moderna USD 2.81B 980M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.25B 1.02B 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Sanofi EUR 10.92B 1.05B 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Takeda JPY 1.11T 68.1B 2023-12
Teva Pharmaceutical Industries USD 4.46B 607M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12
Xencor USD 44.69M 14.48M 2023-12



Seattle Genetics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.